IESE (España)
-
Experimentos para llegar a los pobres sin romper la red de seguridad: el seguro médico público en Massachusetts
Savedoff W.; Murphy C.; García Prat, Antoni; Rosenmöller, MagdaCase P-1005Service and Operations ManagementLa llegada de una nueva Directora a la agencia de programas de asistencia sanitaria del Estado provoca un replanteamiento de los mecanismos de cobertura, costes y calidad del servicio. Tras revisar pasadas iniciativas, la nueva Directora decide emprender una serie de reformas a fin de alcanzar los objetivos señalados de forma significativa. Los cambios implican nuevos sistemas de relación entre el estado, las compañías aseguradoras y los proveedo...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Experiments in reaching the poor without tearing the safety net: public health insurance in Massachusetts
Savedoff W.; Murphy C.; García Prat, Antoni; Rosenmöller, MagdaCase P-1005-EService and Operations ManagementThe arrival of a new director at the state's health program agency leads to a reconsideration of the coverage mechanisms, costs and service quality. After reviewing previous activities, the new director decides to undertake a series of reforms in order to attain the goals that have been set. The changes require a new framework of relationships between the state, the insurance companies and the health providers, creating new opportunities and risk...Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20